Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
1.070
+0.030 (2.88%)
Nov 3, 2026, 1:58 PM EST - Market open
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $3.82 million as of November 3, 2026. It is the 46,016th most valuable company in the world and the 6,120th biggest in the United States. Its market cap has decreased by 86.35% in one year.
Market Cap
3.82M
Enterprise Value
1.43M
1-Year Change
-86.35%
Global Rank
Country Rank
#6,120 United States
Category
ChartMarket Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $3.82M, a decrease of -93.44%. That is a compound annual growth rate of -51.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 3.82M | -75.92% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Liminatus Pharma | 3.79M |
| NeuroSense Therapeutics | 3.68M |
| GRI Bio | 3.34M |
| 60 Degrees Pharmaceuticals | 3.31M |
| PharmaCyte Biotech | 3.24M |
| Eocene | 3.23M |
| Ernexa Therapeutics | 3.22M |
| KALA BIO | 3.20M |